Plasma EGFR mutation ctDNA dynamics in patients with advanced EGFR-mutated NSCLC treated with Icotinib: phase 2 multicenter trial result.
第一作者:
Yaping,Hong
第一单位:
Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 420 Fuma Road, Jin'an District, 350014, Fuzhou, China.;Fujian Key Laboratory of Translational Cancer Medicine, 350014, Fuzhou, China.
作者:
医学主题词
人类(Humans);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);冠醚类(Crown Ethers);女(雌)性(Female);男(雄)性(Male);肺肿瘤(Lung Neoplasms);中年人(Middle Aged);老年人(Aged);喹唑啉类(Quinazolines);突变(Mutation);前瞻性研究(Prospective Studies);成年人(Adult);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents)
DOI
10.1038/s41598-024-73749-2
PMID
39367090
发布时间
2024-11-07
- 浏览1
Scientific reports
23115页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



